APA

Kalgutkar A. S., Tugnait M., Zhu T., Kimoto E., Miao Z., Mascitti V., Yang X., Tan B., Walsky R. L., Chupka J., Feng B. & Robinson R. P. (20120227). Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Kalgutkar Amit S, Tugnait Meera, Zhu Tong, Kimoto Emi, Miao Zhuang, Mascitti Vincent, Yang Xin, Tan Beijing, Walsky Robert L, Chupka Jonathan, Feng Bo and Robinson Ralph P. 20120227. Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Kalgutkar A. S., Tugnait M., Zhu T., Kimoto E., Miao Z., Mascitti V., Yang X., Tan B., Walsky R. L., Chupka J., Feng B. and Robinson R. P. (20120227). Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Kalgutkar Amit S, Tugnait Meera, Zhu Tong, Kimoto Emi, Miao Zhuang, Mascitti Vincent, Yang Xin, Tan Beijing, Walsky Robert L, Chupka Jonathan, Feng Bo and Robinson Ralph P. Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. : Drug metabolism and disposition: the biological fate of chemicals. 20120227.